HEALTH TOPICS 
Gray area for new heart failure drug
Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
A "new" drug called BiDil (it's actually two old ones) is the first medication approved for a particular racial group, in this case blacks with moderate-to-severe heart failure. The interesting thing is, it may work just as well for members of other racial or ethnic groups with this all-too-common condition.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise